Literature DB >> 2896109

Alzheimer's disease as an age-dependent disorder.

R Katzman1.   

Abstract

Alzheimer's disease is the most significant of the age-related diseases of the brain. The incidence of Alzheimer's at age 80 is twenty-fold that at age 60 years. In one study the incidence at age 80 surpassed that of stroke. Three major advances have occurred in regard to Alzheimer's disease: (1) clinical diagnosis has markedly improved and now approaches 90% accuracy; (2) understanding of the biology of Alzheimer's has increased with delineation of specific fibrous protein abnormalities and identification of the amyloid precursor gene and the gene linked to familial Alzheimer's, both genes being located on chromosome 21; and (3) there have been advances in the correlation of specific nerve cell involvement and neurotransmitter changes with physiological (position emission tomography), behavioural and neuropsychological manifestations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2896109     DOI: 10.1002/9780470513583.ch6

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  5 in total

1.  Increasing CREB function in the CA1 region of dorsal hippocampus rescues the spatial memory deficits in a mouse model of Alzheimer's disease.

Authors:  Adelaide P Yiu; Asim J Rashid; Sheena A Josselyn
Journal:  Neuropsychopharmacology       Date:  2011-07-06       Impact factor: 7.853

2.  Progression of neuropsychiatric symptoms in young-onset versus late-onset Alzheimer's disease.

Authors:  Melisa Gumus; Namita Multani; Michael L Mack; Maria Carmela Tartaglia
Journal:  Geroscience       Date:  2021-01-09       Impact factor: 7.581

3.  Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease.

Authors:  Gemma Casadesus; Mark A Smith; Samar Basu; Jing Hua; Dae E Capobianco; Sandra L Siedlak; Xiongwei Zhu; George Perry
Journal:  Mol Neurodegener       Date:  2007-01-22       Impact factor: 14.195

Review 4.  Microglial Function across the Spectrum of Age and Gender.

Authors:  Jillian C Nissen
Journal:  Int J Mol Sci       Date:  2017-03-04       Impact factor: 5.923

5.  MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer's Disease.

Authors:  Paul M McKeever; Raphael Schneider; Foad Taghdiri; Anna Weichert; Namita Multani; Robert A Brown; Adam L Boxer; Anna Karydas; Bruce Miller; Janice Robertson; Maria Carmela Tartaglia
Journal:  Mol Neurobiol       Date:  2018-03-30       Impact factor: 5.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.